CL2015000461A1 - Compuesto derivado de benzotiazolona, agonista beta2-adrenérgico; forma cristalina; proceso de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; metodo para tratar o prevenir distrofia muscular, atrofia relacionada con desuso; caquexia o sarcopenia. - Google Patents
Compuesto derivado de benzotiazolona, agonista beta2-adrenérgico; forma cristalina; proceso de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; metodo para tratar o prevenir distrofia muscular, atrofia relacionada con desuso; caquexia o sarcopenia.Info
- Publication number
- CL2015000461A1 CL2015000461A1 CL2015000461A CL2015000461A CL2015000461A1 CL 2015000461 A1 CL2015000461 A1 CL 2015000461A1 CL 2015000461 A CL2015000461 A CL 2015000461A CL 2015000461 A CL2015000461 A CL 2015000461A CL 2015000461 A1 CL2015000461 A1 CL 2015000461A1
- Authority
- CL
- Chile
- Prior art keywords
- benzothiazolone
- sarcopenia
- disuse
- beta2
- cachexia
- Prior art date
Links
- YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 title 1
- 206010003694 Atrophy Diseases 0.000 title 1
- 206010006895 Cachexia Diseases 0.000 title 1
- 239000000048 adrenergic agonist Substances 0.000 title 1
- 230000037444 atrophy Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 201000006938 muscular dystrophy Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 208000001076 sarcopenia Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IQ23912 | 2012-08-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2015000461A1 true CL2015000461A1 (es) | 2015-05-04 |
Family
ID=53386469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2015000461A CL2015000461A1 (es) | 2012-08-30 | 2015-02-25 | Compuesto derivado de benzotiazolona, agonista beta2-adrenérgico; forma cristalina; proceso de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; metodo para tratar o prevenir distrofia muscular, atrofia relacionada con desuso; caquexia o sarcopenia. |
Country Status (26)
| Country | Link |
|---|---|
| EP (2) | EP2890687B1 (es) |
| KR (1) | KR20150047586A (es) |
| CN (2) | CN104736525B (es) |
| BR (1) | BR112015004127A2 (es) |
| CA (1) | CA2882877A1 (es) |
| CL (1) | CL2015000461A1 (es) |
| CY (1) | CY1120225T1 (es) |
| DK (1) | DK2890687T3 (es) |
| EA (1) | EA029946B1 (es) |
| ES (1) | ES2642003T3 (es) |
| HR (1) | HRP20171362T1 (es) |
| HU (1) | HUE033655T2 (es) |
| IL (1) | IL237382A0 (es) |
| LT (1) | LT2890687T (es) |
| MA (1) | MA37872A1 (es) |
| MX (1) | MX351741B (es) |
| MY (1) | MY169038A (es) |
| NZ (1) | NZ705319A (es) |
| PE (1) | PE20150465A1 (es) |
| PL (1) | PL2890687T3 (es) |
| PT (1) | PT2890687T (es) |
| SA (1) | SA515360076B1 (es) |
| SG (2) | SG11201501293PA (es) |
| SI (1) | SI2890687T1 (es) |
| TN (1) | TN2015000058A1 (es) |
| WO (1) | WO2014033654A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3192B1 (ar) | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20050130A1 (es) | 2002-08-09 | 2005-03-29 | Novartis Ag | Compuestos organicos |
| EP1631260A2 (en) | 2003-02-28 | 2006-03-08 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| CA2565243A1 (en) | 2004-05-13 | 2005-11-24 | Boehringer Ingelheim International Gmbh | Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases |
| GB0426164D0 (en) | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
| JO3192B1 (ar) * | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
| MA38354B1 (fr) * | 2013-02-28 | 2016-09-30 | Novartis Ag | Préparation contenant un composé de benzothiazolone |
-
2013
- 2013-08-29 EP EP13812075.3A patent/EP2890687B1/en active Active
- 2013-08-29 PE PE2015000275A patent/PE20150465A1/es not_active Application Discontinuation
- 2013-08-29 CN CN201380055093.1A patent/CN104736525B/zh not_active Expired - Fee Related
- 2013-08-29 WO PCT/IB2013/058109 patent/WO2014033654A1/en not_active Ceased
- 2013-08-29 MY MYPI2015000453A patent/MY169038A/en unknown
- 2013-08-29 KR KR1020157007573A patent/KR20150047586A/ko not_active Withdrawn
- 2013-08-29 BR BR112015004127A patent/BR112015004127A2/pt not_active Application Discontinuation
- 2013-08-29 EP EP17171708.5A patent/EP3243817A1/en not_active Withdrawn
- 2013-08-29 PL PL13812075T patent/PL2890687T3/pl unknown
- 2013-08-29 DK DK13812075.3T patent/DK2890687T3/en active
- 2013-08-29 SG SG11201501293PA patent/SG11201501293PA/en unknown
- 2013-08-29 MX MX2015002656A patent/MX351741B/es active IP Right Grant
- 2013-08-29 MA MA37872A patent/MA37872A1/fr unknown
- 2013-08-29 HR HRP20171362TT patent/HRP20171362T1/hr unknown
- 2013-08-29 SI SI201330750T patent/SI2890687T1/sl unknown
- 2013-08-29 CA CA2882877A patent/CA2882877A1/en not_active Abandoned
- 2013-08-29 PT PT138120753T patent/PT2890687T/pt unknown
- 2013-08-29 ES ES13812075.3T patent/ES2642003T3/es active Active
- 2013-08-29 EA EA201590452A patent/EA029946B1/ru not_active IP Right Cessation
- 2013-08-29 SG SG10201704377PA patent/SG10201704377PA/en unknown
- 2013-08-29 HU HUE13812075A patent/HUE033655T2/en unknown
- 2013-08-29 LT LTEP13812075.3T patent/LT2890687T/lt unknown
- 2013-08-29 NZ NZ705319A patent/NZ705319A/en not_active IP Right Cessation
- 2013-08-29 CN CN201610537241.9A patent/CN106146428A/zh active Pending
-
2015
- 2015-02-20 TN TNP2015000058A patent/TN2015000058A1/fr unknown
- 2015-02-23 IL IL237382A patent/IL237382A0/en unknown
- 2015-02-25 CL CL2015000461A patent/CL2015000461A1/es unknown
- 2015-02-26 SA SA515360076A patent/SA515360076B1/ar unknown
-
2017
- 2017-09-13 CY CY20171100967T patent/CY1120225T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2890687T (pt) | 2017-10-05 |
| SG11201501293PA (en) | 2015-03-30 |
| CN104736525B (zh) | 2016-08-24 |
| HK1206015A1 (en) | 2015-12-31 |
| CY1120225T1 (el) | 2018-12-12 |
| IL237382A0 (en) | 2015-04-30 |
| CN106146428A (zh) | 2016-11-23 |
| WO2014033654A1 (en) | 2014-03-06 |
| MX351741B (es) | 2017-10-26 |
| SI2890687T1 (sl) | 2017-10-30 |
| SG10201704377PA (en) | 2017-06-29 |
| EP2890687A1 (en) | 2015-07-08 |
| MX2015002656A (es) | 2015-05-20 |
| NZ705319A (en) | 2018-05-25 |
| MY169038A (en) | 2019-02-07 |
| EP3243817A1 (en) | 2017-11-15 |
| SA515360076B1 (ar) | 2016-03-20 |
| EA029946B1 (ru) | 2018-06-29 |
| CN104736525A (zh) | 2015-06-24 |
| ES2642003T3 (es) | 2017-11-14 |
| EA201590452A1 (ru) | 2015-07-30 |
| CA2882877A1 (en) | 2014-03-06 |
| HUE033655T2 (en) | 2017-12-28 |
| DK2890687T3 (en) | 2017-10-09 |
| EP2890687B1 (en) | 2017-06-28 |
| TN2015000058A1 (en) | 2016-06-29 |
| LT2890687T (lt) | 2017-09-11 |
| KR20150047586A (ko) | 2015-05-04 |
| PE20150465A1 (es) | 2015-04-22 |
| PL2890687T3 (pl) | 2017-11-30 |
| BR112015004127A2 (pt) | 2017-07-04 |
| MA37872A1 (fr) | 2018-07-31 |
| HRP20171362T1 (hr) | 2017-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL278912A (en) | Improved preparations for the treatment of muscular dystrophy | |
| CL2014002756A1 (es) | Compuestos derivados de 1,4-benzotiazepina; composición farmacéutica que lo comprende; uso para tratar afecciones relacionadas con función anormal de receptores de rianodina; y método de preparación del compuesto. | |
| EP2970964B8 (en) | Exon skipping compositions for treating muscular dystrophy | |
| PL2984166T3 (pl) | Kompozycje do leczenia mpsi | |
| PL3066080T3 (pl) | Podstawione benzamidy do zwalczania stawonogów | |
| BR112016011065A2 (pt) | Composto cristalino, composição farmacêutica, forma de dosagem, método para tratar anemia | |
| SG10201607603VA (en) | Spin-on carbon compositions for lithographic processing | |
| ZA201603793B (en) | Novel compounds for combating arthropods | |
| BR112015003101A2 (pt) | processo para a preparação de um composto. | |
| IL245805A0 (en) | Process for purifying 5,2-dichlorophenol | |
| BR112014013354A2 (pt) | processo para a preparação de um polímero, composição, composto, e, formulação | |
| BR112013021512A2 (pt) | método para o processamento de material de cátodos, contendo carbono | |
| CL2015001720A1 (es) | Compuesto 6-cloro-3-(fenil-d5)inden-1-ona; proceso de preparacion. | |
| IL257202B (en) | Compounds useful for ror–gamma–t inhibition | |
| SG11201702512RA (en) | Synergistic composition for osteoarthritis | |
| SG11201500211PA (en) | Composition for preventing or treating osteoarthritis | |
| CL2014002817A1 (es) | Compuesto monoclorhidrato de anamorelina que tiene contenido controlado de cloruro; composicion que lo comprende; procedimiento de preparacion del compuesto. | |
| EP3204469A4 (en) | Process for purification of organic composition | |
| PL3313200T3 (pl) | (5r)-(ss-d-glukopiranozyloksy)-1,5-dihydro-2h-pirol-2-on jako cząsteczka umami | |
| CL2015000461A1 (es) | Compuesto derivado de benzotiazolona, agonista beta2-adrenérgico; forma cristalina; proceso de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; metodo para tratar o prevenir distrofia muscular, atrofia relacionada con desuso; caquexia o sarcopenia. | |
| PL2734492T3 (pl) | Sposób wytwarzania 1,1,1-trifluoropropanu | |
| EP3130586A4 (en) | Process for treating homoserine-based compound | |
| EP3085681A4 (en) | Method for purifying hydrofluorocarbon compound | |
| PT3142749T (pt) | Composição para viscossuplementação compreendendo ulvano para tratamento de artrite | |
| SG11201701023YA (en) | Process for hydroxylating phenolic substrate |